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Abstract 
Type III secretion (T3S) is a mechanism central to the biology of the 
Chlamydiaceae as well as many other pathogens whose virulence depends on 
the translocation of toxic effector proteins to cytosolic targets within infected 
eukaryotic cells.  Biomathematical simulations, using a previously described 
model of contact-dependent, T3S-mediated chlamydial growth and late 
differentiation, suggest that chlamydiae contained in small non-fusogenic 
inclusions will persist.  The model is further discussed in the context of in vitro-
persistent, stress-induced aberrantly enlarged forms and of recent studies using 
small molecule inhibitors of T3S. A general mechanism whereby both early and 
mid-cycle T3S-mediated activities and late T3S inactivation upon detachment are 
critical for chlamydial intracellular development is emerging. 
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 EB   elementary body 
IB  initial/intermediate body 
RB  reticulate body 
mRB  aberrantly enlarged RB form induced by stress 
Inclusion parasitophorous vacuole that contains replicating chlamydiae 
Injectisome the T3S machine or “nano-syringe” 
IM  inner (cytoplasmic) membrane 
OM  outer membrane 
T3S  type III secretion 
vir-T3S virulence associated T3S 
fla-T3S flagellar T3S 
cds  “contact-dependent secretion” gene 
cop  “Chlamydia outer protein” gene; ortholog of yop 
scc  “Specific Chlamydia chaperone” gene; ortholog of syc 
Tarp  translocated actin recruiting phosphoprotein 
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A family apart: The Chlamydiaceae 
The Chlamydiaceae and other members of the order Chlamydialesa are 
obligate intracellular bacteria that infect a broad spectrum of multicellular 
organisms including human, animal and insect species, as well as unicellular 
organisms such as free-living amoeba. They are characterized by a unique 
biphasic developmental cycle that initiates when the infectious, metabolically 
inert elementary body (EB) attaches to and enters a eukaryotic host cell. Post-
internalization, the EB differentiates into the non-infectious, but metabolically 
active reticulate body (RB), which replicates by binary fission for several 
generations within a parasitophorous vacuole, termed the inclusion.  Growth and 
multiplication of the RBs continue for 18 to 36 hr, depending on the strain. Upon 
an unidentified late signal(s), RBs differentiate back to EBs via a poorly defined 
form, variably termed the initial or intermediate body (IB).  
In addition to inducing their own internalization, chlamydiae interfere with 
host cell function including subversion of the cytoskeleton to facilitate intracellular 
redistribution of newly internalized EBs [1], early inhibition of apoptosis to ensure 
intracellular survival for the duration of the developmental cycle, and induction of 
cell death [2] to release chlamydial progeny upon completion of the cycle.  The 
endpoint of chlamydial intracellular development is the release of newly made 
EBs associated with the death of the infected host cell thought to involve an 
apoptosis-like mechanism [3-5]. 
RBs that are subjected to stress (e.g. tryptophan starvation, exposure to 
antibiotics or phages) cease to divide although they continue to replicate [6,7], 
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yielding aberrantly enlarged, multinucleated forms that phenotypically resemble 
stress-induced filamentous forms of rod-shaped Gram-negative bacteria.  Like 
other stressed bacteria, these aberrant RBs express elevated levels of stress-
response proteins [8] and do not resume normal growth --and subsequent late 
differentiation in the case of chlamydial RBs-- until the stressor is removed.  
Although these forms are often referred to as persistent chlamydiae, a link with 
clinically “persistent” infection in humans is still unproven.  Hence to avoid 
confusion and by analogy with Gram-negative filamentous bacteria (sometimes 
termed “maxicells”), stress-induced forms are referred to as maxi-RBs (mRBs) in 
this review. 
The genetic intractability of Chlamydia has made direct functional analysis 
of suspected virulence factors prohibitively difficult.  Moreover, experimental 
reproducibility often suffers from systematic contamination with “variant” 
chlamydiae and bacterial or eukaryotic debris as clonal isolation and purification 
of these obligate intracellular organisms is difficult. Because of these limitations, 
Chlamydia researchers have resorted to alternative approaches such as 
comparative analyses with better characterized systems, and the use of 
surrogate systems whenever possible.  Comparative analysis of the highly 
conserved genomes --a “poor-man’s” genetic system in Chlamydia research-- for 
instance, has led to the identification of tryptophan synthase as a key 
determinant of organ tropism in C. trachomatis infection [9].  
We examine here the genetic organization and protein machinery of one 
of the better studied pathways of Chlamydia sp., the type III secretion (T3S) 
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system that mediates the translocation of bacterial toxins to the cytosol of 
infected cells in several important Gram negative bacterial pathogens. Based on 
early ultra structural observations, we have previously proposed the T3S-
mediated contact-dependent hypothesis, whereby chlamydiae replicate strictly in 
contact with the inclusion membrane, while detachment and coupled T3S 
inactivation constitute the signal for late differentiation.  The hypothesis is now 
expended through biomathematical simulations predicting persistence of 
chlamydiae under conditions where multiple inclusions are formed in a single 
cell, and discussed in the context of the chlamydial response to stress and 
inhibition of T3S. 
 
Type III secretion of a different type 
T3S, which facilitates the direct translocation of bacterial virulence factors 
to the cytosol of the target eukaryotic cell [10] (vir-T3S), has been described in 
major human pathogens such as Yersinia, Salmonella, Shigella, 
Pseudomonas aeruginosa, pathogenic E. coli, and the Chlamydiaceae, as well 
as in bacteria infecting plants [11,12].  Recently, vir-T3S genes have also been 
identified in the genomes of environmental Chlamydia species, Candidatus 
Protochlamydia acanthamoeba [13] and Simkania negevensis (Myers et al., 
unpublished), both of which grow in amoeba [13,14]. In some pathogens, e.g. S. 
enterica serovar Typhimurium (S. Typhimurium) [15] and Y. enterocolitica [16], 
multiple vir-T3S systems encoded within unlinked pathogenicity islands or 
plasmids have been described.  Although the function of each individual vir-T3S 
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system is not clear, it is thought that the multiple systems are functionally distinct.  
The SPI-1 system of Salmonella for example is important for invasion of target 
cells [17], whereas the unlinked SPI-2 system is critical for intracellular growth 
and survival [15,18]. 
A genomic T3S pathogenicity “archipelago” 
Across the Chlamydiales, genes encoding the structural proteins of the vir-
T3S apparatus are found in three distinct conserved genomic clusters (Fig. 1) 
while genes encoding putative translocator proteins and flagellar-associated T3S 
(fla-T3S) proteins are at unlinked genomic sites in the Chlamydiaceae, and are 
apparently absent in the Parachlamydiaceae. The molecular G+C content of 
each chlamydial T3S cluster is close to 40%, similar to the rest of the genome 
and there are no apparent vestiges of recent integration events such as IS 
elements or repeats. This stands in sharp contrast with vir-T3S genes of other 
Gram-negative bacteria, whose clustering in chromosomal pathogenicity islands 
or on plasmids suggests that they have been acquired recently by horizontal 
gene transfer from a heterologous donor [19].  Figure 1 reveals that all 
Chlamydia sp. have conserved T3S clusters, both in gene content and genomic 
location, with the exception of two clusters of C. trachomatis and C. muridarum 
that are inverted relative to ori.  A comparison of chlamydial T3S gene order with 
that of the T3S plasmid (pCD1) of their closest phylogenetic relative, Y. pestis, 
reveals loose similarities (Figure 1). It is however unclear whether T3S genes 
that appear to be missing in Chlamydia relative to Yersinia are truly missing or 
simply distantly related, hence unannotated as T3S homologs in genome 
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sequences.  These differences may reflect a T3S injectisome that is functionally 
adapted to the developmental biology of Chlamydia and the need of this 
organism to survive host defenses on both sides of the eukaryotic plasma 
membrane.  
What are chlamydial flagellar T3S genes for?  
It is not currently known whether contemporary vir-T3S systems have 
evolved from an ancestral flagellar T3S (fla-T3S) system [20] or if both vir- and 
fla-T3S systems have evolved independently from a common ancestor [21].  
Chlamydia represents a microcosm of this unresolved question as, in addition to 
vir-T3S genes, all members of the Chlamydiaceae examined to date, although 
they are non motile organisms, possess a subset of fla-T3S genes.    
Several fla-T3S genes annotated as flhA, fliF, and fliI (homologs of cdsV, 
cdsJ, and cdsN) are present in two genomic clusters in all genomes of the 
Chlamydiaceae.  These genes are not found in Protochlamydia or Simkania 
suggesting that their selective acquisition by the Chlamydiaceae –or loss by the 
Parachlamydiaceae-- may have played a role in the transition of ancestral 
chlamydiae from unicellular to multicellular hosts.  FlhA, an essential component 
of the flagellar export apparatus, is normally housed within the FliF basal-body 
MS (membrane and supramembrane) Ring, where it also interacts with the 
flagellar ATPase FliI and its specific inhibitor protein FliH [22].  fliA, encoding 
Sigma-28 involved in flagellar gene transcriptional regulation in other bacteria, is 
immediately downstream of flhA in all chlamydial genomes.  Although microarray 
and proteomic experiments have indicated that these genes are expressed at 
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mid cycle [23], their function remains a mystery as they potentially encode only a 
portion of the flagellar basal body.   Do these genes encode a simplified form of a 
flagellum that provides motility within the inclusion? If so, what other gene 
products compose the putative flagellum?   Are the chlamydial flagellar proteins 
able to interact with the vir-T3S injectisome, i.e. do they represent a reductive 
evolution solution to the need for multifunctional T3S systems? Or do these 
genes have an entirely novel function which cannot be inferred from sequence 
similarity with other systems?  
 
The chlamydial T3S machine 
All chlamydial genomes encode multiple conserved proteins of the vir-T3S 
injectisome, a molecular “nano-syringe” made of about 20-25 proteins, the 
translocator apparatus, and chaperone subclasses, which together are required 
for the assembly and functioning of the T3S pathway [24]. Conserved 
components of the chlamydial T3S machine are succinctly described in Table 1 
and represented graphically in Figure 2.      
The chlamydial injectisome 
The predicted lipoprotein, CdsJ, is predicted to span the periplasmic 
space and associate with integral membrane proteins CdsR-V. CdsJ also likely 
interacts with the inner membrane protein CdsD that has also been detected in at 
the surface of C. trachomatis EBs (ORF664 in Tanzer et al [25]). The highly 
conserved N-terminus of CdsV displays seven predicted transmembrane 
domains, while the large C-terminus region is less conserved, more hydrophilic 
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and is predicted to be localized in the cytoplasm where it may interact with 
effector proteins, chaperones or other T3S apparatus proteins. The outer 
membrane ring of the injectisome, which is necessary for the T3S needle to 
cross the outer membrane, is composed of CdsC, a homolog of YscC of 
Yersinia.  In other systems, the ring forms hexameric structures similar to the 
“rosette-like” structures observed by Matsumoto [26]. The inner diameter of the 
chlamydial rosettes, estimated at 4-5 nm, is similar to the inner diameter of the 
Yersinia outer ring at 4.5 nm [27] and close to that of the Salmonella outer ring at 
7nm [28].  
The translocator proteins 
CopB, and its paralog CopB2 of C. trachomatis, are homologs of the 
Yersinia T3S translocator protein YopB and as such, are predicted to act as the 
entry point for the T3S needle and to facilitate translocation of secreted effectors 
across the plasma membrane of the eukaryotic host cell.  CopB is detectable in 
the inclusion membrane after infection, consistent with its presumed function as a 
T3S translocator.  In contrast, CopB2 is detected in the host cell cytosol [29], 
possibly reflecting a function for chlamydial translocator proteins distinct from that 
in other species, where only one copy of the gene is present.  Similar to enteric 
T3S, a single CopB homolog is also found in Protochlamydia. 
 
Effector proteins  
In contrast to apparatus components, T3S effectors display little sequence 
homology although they often display common structural features and have 
similar enzymatic activities across bacterial genera.  In other systems, effectors 
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harbor a variety of toxic effects ranging from cytoskeletal alterations, subversion 
of signal-transduction pathways, repression or activation of apoptosis, and may 
also disrupt host transcriptional regulation [12,30].  By analogy with other 
systems, effector proteins may be either secreted into the inclusion lumen, to 
potentially attack the host cell via receptors at the surface of the inclusion 
membrane, are deposited in the inclusion membrane, or are translocated directly 
to the cytosol of the host cell.  
Attempts to identify T3S effector proteins of the Chlamydiaceae have had 
varied success.  Supportive evidence may include direct sequence or secondary 
structure similarity with T3S effectors of other species and, possibly, linkage to or 
co-precipitation with other T3S orthologs [29,31].  A more reliable indicator is the 
demonstration of T3S-mediated secretion or translocation of a candidate effector 
by a surrogate host bacterium [29,32-35].  An extension of this strategy to the 
testing of T3S-dependent secretion by S. flexneri of hybrid proteins composed of 
a predicted T3S signal sequence fused to adenylate cyclase identified 24 new 
candidate effectors [36].  However, this method also identified several proteins 
that are not known and/or not likely to be secreted, including orthologs of FliH 
(CPn0859), a predicted arginine decarboxylase (CPn1032) and a beta-
lactamase-like metal-dependent hydrolase (CPn0879) (Mark Pallen, personal 
communication).  Notwithstanding the questionable reliability of surrogate T3S 
systems, several candidate effectors have been identified, the most prominent of 
which are briefly discussed below. 
Tarp  
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The Tir-like effector protein Tarp is translocated via T3S by 
Y. pseudotuberculosis and is involved in the recruitment of actin to the C. 
trachomatis inclusion [35].  Like Tir, the translocated receptor for entero-
pathogenic E. coli [37], Tarp may function as a receptor for an unidentified 
chlamydial intimin analog.  Since the T3S machine is functional early [38], it is 
conceivable that Tarp is “preloaded” in the T3S needle of the EB so as to 
mediate early cytoskeletal changes during internalization [39].   In addition, Tarp-
mediated actin recruitment may be to build a cytosolic “track” for Chlamydia-
ladden inclusions. Tarp is activated upon tyrosine-phosphorylation by an 
unidentified eukaryotic kinase [40], as is the case for many other secreted 
virulence factors [41]. Likewise, Tir is phosphorylated by the protein kinase Fyn 
[42] a member of the Src kinase family [41]. The existence of a Src consensus 
motif in Tarp strongly supports that it is also phosphorylated by a Src kinase.  
Inc proteins 
Chlamydial T3S effectors include inclusion membrane proteins IncA, IncB, 
and IncC, whose C. pneumoniae orthologs are secreted by the S. flexneri T3S 
system [33]. IncC of C. trachomatis is also demonstrably translocated into the 
cytosol of HeLa cells by the Y. enterocolitica T3S system [38].  IncA is located on 
the outer face of the inclusion membrane toward the cytosol and is involved in 
the homotypic fusion of multiple inclusions of C. trachomatis [43,44] but not of 
sphingomyelin-containing vesicles [45]. IncA also forms long fibers extending 
from the inclusion that are used as cytosolic tracks mediating the formation of 
 14
secondary inclusions [46].  Transfection of incA into eukaryotic cells blocks 
normal chlamydial development in these cells [47,48]. 
CopN 
A homolog of the Yersinia T3S regulator YopN, CopN is translocated in a 
T3S-dependent manner by Y. enterocolitica [29,32] and S. Typhimurium (SPI-1) 
[34].  Demonstrated late copN expression [49,50] is consistent with CopN being 
involved both in T3S down regulation and physical shutoff of the injectisome as 
RBs start differentiating into IBs.  YopN similarly is thought to block the T3S 
channel through a conformation-dependent interaction with its chaperone and a 
cytoplasmic membrane site of the T3S injectisome [51].  Contact with a 
susceptible cell (or removal of calcium in vitro) is presumed to disrupt this 
interaction, allowing YopN secretion and subsequent unblocking of the channel 
for other Yops.  A direct comparison between YopN and CopN is not necessarily 
justified in view of the phylogenetic distance and biological disparities between 
Chlamydia and Yersinia.  However, it is worth noting that similar roles for CopN 
and YopN are still possible since late expressed chlamydial proteins are likely to 
mediate early events in chlamydial pathogenesis. 
 
The T3S contact-dependent development hypothesis 
Chlamydia in the pre-omic era 
Starting in 1973, nearly 20 years before the earliest description of the T3S 
system in Yersinia [52], Matsumoto and colleagues published electron 
micrographs showing rosette-like structures and projections at the surface of 
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Chlamydia psittaci strain Mn [26,53-55].  These and similar structures have since 
been observed at the surface of C. trachomatis [56], C. caviae [57], C. 
muridarum [58], C. pneumoniae [59] EBs and have become known as 
Matsumoto’s projections.  In a few of the published micrographs, Matsumoto was 
able to demonstrate that the projections were anchored in the cytoplasmic 
membrane, extended through the outer membrane of the chlamydiae (Figure 
3B), and that a cluster of hexagonally-arrayed projections delineated a zone of 
contact between the bacterium and the plasma membrane-derived inclusion 
membrane (Figure 3).  Based on their analogies with T3S systems, we have 
previously proposed that Matsumoto’s projections were in fact T3S injectisomes 
[60].  This hypothesis, while still begging for immunochemical, biochemical or 
genetic confirmation, is consistent with physiological and structural properties of 
T3S injectisomes.  However, any model for chlamydial development that is built 
on the identity of the T3S machinery and Matsumoto’s projections, including that 
developed in the paragraphs below, must be preceded by the caution that it 
remains an unverified hypothesis. 
The size of the projections’ patch decreases during development  
Chlamydial surface projections are organized as a regular hexagonally 
arrayed patch located at one pole of both developmental forms of the bacterium.  
Matsumoto observed that within a patch of C. psittaci strain Mn, the number of 
projections may vary from as low as 11 in the smaller patch of the EBs to as 
many as 83 in the larger patch of the RBs [54].  We previously hypothesized that 
the patch of projections observed on individual chlamydiae represents the fixed, 
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imprinted memory of the contact area between the chlamydial surface and the 
inclusion membrane and that “fixation” might occur late upon general oxidation of 
surface disulfide bonds [60].  Moreover, we speculated that the decrease in the 
number of projections during late differentiation signified that the contact area 
was being reduced as the number of replicating chlamydiae progressively 
exceeded available space at the inclusion membrane surface and were being 
physically “squeezed out”.  An implication of this was that detachment from the 
inclusion membrane could represent the signal for late differentiation [60,61], 
echoing a previous suggestion by Hackstadt [62].  The proposed identity of T3S 
injectisomes and surface projections added a new dimension to this hypothesis 
in that it implied that T3S played an essential role in sustaining replication and 
conversely, that loss of T3S activity through loss of contact could be the signal 
for late differentiation.  The presence of T3S projections on the EB further 
suggested a potential role for T3S, possibly through preloaded effectors, during 
the initial steps of infection. 
Box 1: A biomathematical model of chlamydial development 
  Can mathematics succeed where genetics has so far failed?  The T3S 
contact-dependent hypothesis was analyzed through biomathematical modeling 
[63]. Modeling the hypothesis formalizes its assumptions, quantifies it in 
alignment with experimental observations, and produces testable predictions of 
its implications. Biomathematical modeling can produce outcomes that are the 
logical conclusion of a number of given assumptions; the outcomes may be 
beyond first-level intuition but can be explained by the mechanistic model 
 17
components and in terms of the underlying assumptions in the equations. The 
current hypothesized biological model can be expressed mathematically by three 
differential equations, representing the rate of change in the number of RBs (R), 
IBs (I), and EBs (E) over time along the developmental cycle: 
   
These equations take into account parameters that are either known or 
confidently estimated, such as the volume of space occupied by detached 
chlamydiae in an inclusion (V), the average number of projections post-infection 
derived from Matsumoto’s observations (p(t)), and the doubling time of RBs 
during exponential growth (td). The model has been useful to verify the 
plausibility of the T3S contact-dependent hypothesis and to predict the testable 
implication of persistence according to constrained geometry. Once more 
experimental data becomes available, the model can be further fine-tuned and 
more complexity introduced.  
 
Box 2: Utility and limitations of biomathematical modeling  
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A specific limitation of biomathematical modelling owes to the quality and 
quantity of available measurements used to inform the development of model 
equations and parameters.  In Chlamydia research, this is a significant hurdle as 
the organism presents an unusual degree of experimental difficulty.  For 
example, the number of projections over developmental time has only been 
measured once in a single Chlamydia species [54].  This result was obtained 
long before T3S was discovered and laid nearly forgotten for 20 years.  
Matsumoto’s data has been used as an estimate of projection numbers in the 
model, and the model is calibrated to this data so that it produces normal 
developmental time courses similar to observations. Future improved 
measurements will continuously test the model and allow its refinement. This in 
turn will provide a quantitative framework against which other measurements can 
in turn be tested. 
This model is also deterministic in nature, not accounting for general 
stochasticity, especially for very small numbers of particles. Future models could 
incorporate greater geometrical features so that more specific predictions can be 
made. With any mathematical model, care must be taken with the assumptions 
that underlie it and they should be made explicit. If an important assumption used 
in a model is incorrect, then all subsequent model outcomes will be biased 
accordingly. The current model explicitly makes certain assumptions (such as 
RBs replicate only in contact with the inclusion membrane and they detach from 
the membrane once the number of projections decreases to a threshold level). 
The mathematical model is adequate to explore the outcomes of these 
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assumptions and the model results are, by nature, implications of this hypothesis. 
The model is not valid outside these assumptions.    
Mathematical modelling is an under-exploited area of biology. Productive 
application of mathematics to biological systems should be evaluated on a case-
per-case basis.  But the Chlamydia system lends itself exquisitely to modelling 
because it is a “closed” system, i.e. most of chlamydial biology occurs within the 
physically restricted, measurable space of the infected cell.  A highly significant 
asset of the chlamydial model is that “simulations” that mimic real biological 
events can be produced easily; for example, the cases of in vitro persistent 
aberrantly enlarged mRBs and multiple inclusions are simulated by altering input 
parameters and re-running the computerized model.  Mathematical modeling 
allows in silico experiments to be run and re-run with different parameters at no 
real costs, whereas wet lab experiments are expensive and time-consuming. 
Modeling can predict specific relationships and threshold levels critical for 
development and can determine sensitivity relationships between outcomes and 
experimental conditions. Experimentation can produce results that modeling can 
attempt to describe and explain, and then modeling can inform experimental 
design and provide experimentally testable predictions. As has occurred in 
physics for many decades, experimentation and modeling theory are highly 
compatible and complimentary disciplines, but their union in biological 
applications is currently under-developed and could be utilized considerably 
more. 
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T3S mediates intracellular development  
The involvement of chlamydial T3S in growth and development is a 
departure from the role of T3S in other pathogens where T3S is indispensable for 
infection but dispensable for growth. This hypothesis for modulation of growth 
has been shown to be consistent with observations and preliminary mathematical 
modeling analyses [63].  We now revisit and extend the model to encompass two 
alternate outcomes of chlamydial growth: the development of inclusions that 
persist in vitro and that of multiple inclusions.  Essential steps and presumed 
effector involvement are represented graphically in Figure 4. 
The strength of the model is that it reconciles many old and new 
observations and provides a unified concept of chlamydial growth and 
differentiation across species boundaries.  For instance, progressive detachment 
from the inclusion membrane is consistent with the perennially observed lack of 
developmental synchronicity such that EBs, IBs and RBs coexist in the late 
inclusion, even after careful synchronization of the initial infection step.  The 
model however is also noteworthy in that it goes against the commonly held 
belief that chlamydiae are able to replicate free in the lumen of the inclusion, i.e. 
out of contact with the inclusion membrane. This belief is based on observation 
accumulated during nearly 40 years of growing chlamydial inclusions by 
transmission electron microscopy (TEM).  Indeed, TEM which reproducibly 
generates high contrast images also reproducibly introduces systematic 
“displacement” artifacts owing to the harsh dehydration conditions, subsequent 
embedding in a resin and thin-sectioning. 
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 Box 3: Are small, non-fusogenic inclusions persistent? 
The number of inclusions per infected cell varies between species and 
within species. Multiple inclusions within a cell may arise from initial infection by 
multiple EBs or by inclusion division. Conversely, multiple inclusions within a cell 
may fuse to form a single late inclusion. In C. trachomatis, inclusion fusogenicity 
is modulated by the type III secreted protein IncA, whereby inclusions containing 
mutant incA do not fuse [43].  Biomathematical simulations indicate that varying 
the number (N) of inclusions per cell increases EB progeny up to N≈5, and 
decreases thereafter (below).   
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This is a logical result: as the number of inclusions increases, there is 
increased RB surface area in contact with the inclusion membrane and this 
facilitates greater growth overall until space becomes restrictive (only once there 
are ~5 inclusions). Increased numbers of inclusions implies that the size of each 
inclusion decreases so that available luminal volume for detached RBs is 
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restricted. Therefore, the T3S contact-dependent model predicts that chlamydial 
species that tend to produce multiple inclusions will be characterized by RBs that 
do not detach from the inclusion membrane but “persist” as RBs. Although this 
has not been investigated systematically, it is well-known that chlamydial species 
that produce multiple or lobar inclusions (e.g. C. pneumoniae and many 
veterinary Chlamydia species) tend to grow “forever” in vitro and/or are 
characterized by inclusions tightly packed with RBs devoid of luminal space. 
Non-fusogenic strains of C. trachomatis are also more frequently associated with 
sub-clinical, “persistent” infection than are their fusogenic counterparts [64]. 
 
In vitro-persistence is a “consequence” of the model 
The phenomenon known as in vitro-persistence, which results from 
exposing chlamydiae to stress, provides strong indirect support to the model as 
well as to the predicted persistence of small inclusions (see Box 3). Stressed 
mRBs are aberrantly enlarged, typically reside within relatively small inclusions 
and are therefore characterized by the same physical constraints as normal-
sized, ‘persisting’ RBs in multiple inclusions, albeit on a different spatial scale.  
Whether RBs (or mRBs) are attached or detached from the inclusion 
membrane is directly linked to whether T3S-mediated translocation of effectors to 
the host cytosol is on or off. This leads to the hypothesis that T3S turn-off on its 
own (i.e. with or without detachment) may be the signal for late differentiation and 
that detachment merely facilitates the process. Comparative transcriptomics of 
normal vs. IFN-gamma induced in vitro-persistent C. trachomatis indicate that 
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transcription of T3S genes is unaffected [23], suggesting that mRBs continue 
expressing and assembling T3S injectisomes at near normal rates. The net result 
should be more T3S injectisomes per mRB (compared to normal RBs), 
contributing to tether the mRB to the inclusion membrane. The T3S effector 
CopN is not expressed in these cells and is only expressed late in normal RBs, 
coincidental with the expression of the cysteine-rich outer membrane protein 
OmcB, i.e. at the developmental stage where the first late developmental forms 
are usually observed. A chicken-and-egg question then becomes: Does CopN 
provoke RB detachment and coupled T3S shut-off, or is CopN expression a 
consequence thereof? Recent evidence for cytosolic targets of CopN in late 
infected cells (Peters & Bavoil, unpublished) favors the former mechanism, albeit 
tenuously. 
Small chemical inhibitors of T3S inhibit development 
Small chemical compounds that belong to a class of acylated hydrazones of 
salicylaldehydes have been recently shown to specifically inhibit T3S and to 
significantly alter development as demonstrated by a dramatic reduction in the 
infectious EB yield [65-67].  One such compound, INP0010, coincidentally 
inhibited T3S and development in C. pneumoniae infected cells [67].  Two other 
compounds, C1 [65] and INP0400 [66] were able to block T3S-mediated 
secretion of IncA of C. trachomatis, resulting in the inhibition of homotypic vesicle 
fusion and formation of multiple small inclusions.  INP0400 inhibition, but not C1 
inhibition, was coupled with the detachment of RBs from the inclusion 
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membrane.    An important question then becomes how to reconcile these 
findings with our prediction that T3S inactivation provokes late differentiation.   
A major difference between the predicted late T3S inactivation upon 
detachment and inhibition with small chemical compounds is in the timing. In our 
model T3S inactivation occurs “naturally” upon detachment, i.e. presumably after 
all T3S effectors have been secreted. Chemical inhibition applied at the onset of 
infection in contrast may target T3S-mediated secretion of early and mid-cycle 
effectors, which are necessary for growth, further development, and presumably 
further T3S. The observation that compound C1 added late (15 hours post-
infection) still inhibits C. trachomatis development [65] suggests that this inhibitor 
may alter secretion of a late effector. It is also intriguing that different inhibitors 
appear to have opposed activities on systems that are very similar.  For instance, 
INP0010 inhibits C. pneumoniae T3S, has no effect on T3S of the closely related 
C. trachomatis, but blocks that of the more distant Yersinia pseudotuberculosis 
[67].  This is indicative of a high level of specificity that suggests that secretion of 
a specific effector(s), or the effector itself, is the target of the inhibition.  The 
contact-dependent hypothesis developed here and recent results of small 
inhibitor studies are overall consistent with a model proposed by Wolf and 
collaborators whereby signals governing development are transduced back 
through the T3S apparatus [65] by a specific mid-cycle to late effector.  Failure to 
transduce these signals or failure to secrete the effector would down-regulate 
late T3S expression and/or function resulting in a developmental block.  Although 
inhibitors studies are still in their infancy and the actual targets of these inhibitors 
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are not known, they hold the potential for unraveling some of the most intricate 
aspects of chlamydial biology while at the same time providing new avenues for 
therapeutic intervention. 
Conclusion 
The presence of T3S genes in all Chlamydia species examined to date 
suggests that T3S is essential to the survival of these bacteria.  This is a 
fundamental difference with other pathogens in which T3S may be optionally 
present or where it can be inactivated by mutation without penalty to the 
bacterium.  A mathematical model based on the strict replication of chlamydiae in 
T3S-mediated contact with the inclusion membrane, predicts that loss of contact 
and coupled T3S inactivation constitutes the signal for late differentiation. 
Biomathematical simulations suggest that chlamydiae contained in multiple small 
inclusions will persist as do stress-induced aberrantly enlarged mRBs.  Although 
this simple model is applicable to Chlamydia across species boundaries, future 
refinements based on new findings, e.g. differential activities of small molecule 
inhibitors of T3S in different species, will introduce complexity reflecting specific 
host-pathogen interactions that can be further simulated biomathematically.  
Notwithstanding predictable variations on the theme, the model and observations 
reported above suggest that the fundamental role of T3S in the success of 
Chlamydia as a parasite may be to modulate its efficient growth and 
development inside the host, a role that may overshadow its presumed role in 
virulence. 
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Footnote: 
aThe “compromise” Chlamydiaceae taxonomy of Kalayoglu and Byrne 
(http://141.150.157.117:8080/prokPUB/chaprender/jsp/showchap.jsp?chapnum=
335) is used in this article. 
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Tables and Figures 
 
Table 1.  Components of the chlamydial T3S machine and secreted 
effectors. Fla-T3S homologs present in Chlamydia are in bold. 
 
Figure 1: Multiple T3S gene clusters in the Chlamydiales.  T3S gene 
clusters of C. trachomatis [68], C. caviae [69], Candidatus P. amoebophila [13] 
and S. negevensis (Myers et al., not shown) (see legend to Fig. 1) are displayed 
using the cdsN cluster as a reference.  The pCD1 T3S gene cluster of Y. pestis is 
shown for comparison. Gene names and ORF numbers are listed above and 
below each gene when available at the TIGR Comprehensive Microbial 
Resource database (www.tigr.org/).  Not drawn to scale. 
 
Figure 2: Diagram of the chlamydial T3S machine. The putative 
structure of the chlamydial injectisome is derived by comparison with the Yersinia 
vir-T3S and Salmonella fla-T3S apparati (http://www.genome.jp/kegg/) [24].  
Stipples identify components for which a paralogous fla-T3S protein (in 
parentheses) is found in the Chlamydiaceae. 
 
Figure 3: Details of the RB interaction with the chlamydial inclusion 
membrane. HeLa 229 cells infected with C. caviae GPIC were examined by 
scanning (A) and transmission (B) electron microscopy. T3S projections (red 
arrows) are viewed from the cytosolic side of the infected cell extending across 
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the inclusion membrane from underlying RBs (A), or in cross-section of an RB 
bound to the inclusion membrane (B) with needle-like structures. In (B), the patch 
of projections delineates the area of contact between the RB and the luminal face 
of the inclusion membrane. (Courtesy of Professor Akira Matsumoto). 
 
  Figure 4: Graphic representation of T3S-mediated chlamydial 
development.  The diagram highlights the predicted dependence of key stages 
of chlamydial infection on a functional T3S system from internalization to the 
onset of late differentiation. These include the translocation of preloaded Tarp 
during internalization (left); the role of IncA, mutant IncA* or down-regulated IncA 
in inclusion fusogenicity (top); the increased area of contact (and consequent 
T3S activity) between stress-induced mRBs and the inclusion membrane 
(bottom); and the coincidental expression and secretion of CopN during late 
differentiation (middle).  The figure and time scales are approximate.   
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